Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1Advanced Gastrointestinal Malignancies 1Adenocarcinoma of the Stomach 1

Interventions

Gemcitabine 4Fluorouracil 4dehydroftorafur 3Taxes 3Oxaliplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Radiotherapy 2Leucovorin 2Irinotecan 2tocilizumab 1selicrelumab 1niraparib 1indusatumab 1cobimetinib 1atezolizumab 1X-Rays 1Tiragolumab 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1PEGPH20 1Nivolumab 1Losartan 1Ipilimumab 1Folfox protocol 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pancreatic Adenocarcinoma × indusatumab × Clear all
NCT02202785 2017-05-15

A Study of MLN0264 in Patients With Pancreatic Cancer

Takeda

Phase 2 Terminated
43 enrolled 22 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡